We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

93 hedge funds and large institutions have $425M invested in Five Prime Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 11

275% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 8

31% more funds holding

Funds holding: 7193 (+22)

15% more capital invested

Capital invested by funds: $369M → $425M (+$56M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
93
Holders Change
+22
Holders Change %
+30.99%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
30
Increased
42
Reduced
11
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TRSOTSOK
51
Teachers Retirement System of the State of Kentucky
Kentucky
$720K -$48K -1,900 -6%
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
$719K +$794K +31,477 New
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$703K
TD Asset Management
54
TD Asset Management
Ontario, Canada
$642K +$225K +8,900 +46%
TA
55
Teachers Advisors
New York
$627K +$87.5K +3,468 +14%
TAM
56
Tocqueville Asset Management
New York
$594K +$322K +12,775 +97%
ProShare Advisors
57
ProShare Advisors
Maryland
$551K +$155K +6,141 +34%
SIP
58
Stoneridge Investment Partners
Pennsylvania
$501K +$553K +21,905 New
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$480K +$530K +20,986 New
Goldman Sachs
60
Goldman Sachs
New York
$459K +$241K +9,549 +91%
BBA
61
Baker Bros. Advisors
New York
$440K -$14.5K -576 -3%
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$426K +$117K +4,650 +33%
AL
63
Airain Ltd
Guernsey
$401K +$443K +17,552 New
BG
64
BlackRock Group
United Kingdom
$385K +$124K +4,895 +41%
TI
65
Telemetry Investments
New York
$343K +$379K +15,000 New
MLICM
66
Metropolitan Life Insurance Company (MetLife)
New York
$322K
Two Sigma Advisers
67
Two Sigma Advisers
New York
$322K +$356K +14,100 New
Deutsche Bank
68
Deutsche Bank
Germany
$315K -$252K -9,974 -42%
VOYA Investment Management
69
VOYA Investment Management
Georgia
$290K
State Board of Administration of Florida Retirement System
70
State Board of Administration of Florida Retirement System
Florida
$273K +$16.2K +640 +6%
DekaBank Deutsche Girozentrale
71
DekaBank Deutsche Girozentrale
Germany
$267K +$295K +11,700 New
AIG
72
American International Group
New York
$256K +$8.83K +350 +3%
PNC Financial Services Group
73
PNC Financial Services Group
Pennsylvania
$252K
Tudor Investment Corp
74
Tudor Investment Corp
Connecticut
$234K +$258K +10,228 New
SCA
75
Secor Capital Advisors
New York
$222K +$245K +9,720 New

FPRX Hedge Fund Activity: Q1 2015 in Review

93 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q1 2015, worth a combined $425M — up 15% from $369M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new FPRX positions and 8 closed out — a net gain of 22 holders — while 42 added to existing stakes and 11 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $24.9M. The largest seller was TPG Group Holdings (SBS) Advisors, exiting entirely with an estimated $28.4M sold.

  • 93 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q1 2015, up from 71 in Q4 2014.
  • Funds reported $425M of Five Prime Therapeutics, Inc. stock for Q1 2015, up 15% quarter-over-quarter.
  • 30 funds opened new Five Prime Therapeutics, Inc. positions in Q1 2015 and 8 closed out, a net change of +22 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q1 2015 was Wellington Management Group, an estimated $24.9M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q1 2015 was TPG Group Holdings (SBS) Advisors, an estimated $28.4M sold.

Based on aggregated 13F filings for Q1 2015.